HIV 1 News and Research

RSS

WHO expert: Faster MDR-TB test should be made available to vulnerable populations

A new diagnostic tool that shortens the diagnosis of multidrug-resistant tuberculosis (MDR-TB) from eight weeks to two hours should be made available to vulnerable populations according to a WHO expert, Reuters reports.

31 Jul 2010

Research establishes bases of possible future pharmaceutical drugs to combat AIDS virus

The doors are closing on the AIDS virus. The scientific community continues to strive to find the formula that will halt the advance of one of the viruses that has sparked most scientific interest over recent years. A study by the Consejo Superior de Investigaciones Cient-ficas (CSIC) and led by Mr F-lix Go-i, director of the Biophysics Unit at the CSIC-University of the Basque Country Mixed Centre, has developed a method of attack against the AIDS virus The method involves creating a prevention system, i.e. an 'armour' in the cells that are likely to be infected and thus impede, de facto, the virus from accessing them and starting to act on their immunological system.

31 Jul 2010

Consumers who have MMS should stop using it immediately, FDA warns

The U.S. Food and Drug Administration is warning consumers not to take Miracle Mineral Solution, an oral liquid solution also known as "Miracle Mineral Supplement" or "MMS." The product, when used as directed, produces an industrial bleach that can cause serious harm to health.

31 Jul 2010

Research Roundup:COBRA subsidies; Children's insurance and dental coverage; Adopting health IT; Race and heart treatments

Archives of Internal Medicine: Racial Differences In Admissions To High-Quality Hospitals For Coronary Heart Disease - "Racial disparities in the management of coronary heart disease (CHD) are widely documented, yet the reasons behind persistent gaps in quality of care are not fully understood," write the authors, who examined "Medicare patients with acute myocardial infarction and coronary artery bypass grafting (CABG) admitted during 2002 through 2005 to hospitals located in markets with top-ranked cardiac hospitals, as ascertained from the US News and World Report 'America's Best Hospitals' annual rankings."

31 Jul 2010

Opinions: IDUs and HIV; AIDS 2010; International Violence Against Women Act

In a Los Angeles Times opinion piece, Evan Wood, associate professor of medicine at the University of British Columbia, writes about the Vienna Declaration, a document he helped to draft, that calls for international leaders to revise drug policies to incorporate greater scientific evidence and promote HIV prevention, treatment and care for drug users.

31 Jul 2010

Recent releases in Global Health

A Center for Global Development memo offers suggestions for the U.S. to improve its commitment to policies that benefit poor countries after it ranked 17th out of 22 wealthy in the 2009 Commitment to Development Index. Among a set of 20 recommendations, the authors suggest the U.S. "[i]ncrease foreign aid, especially through such vehicles as the Millennium Challenge Corporation (MCC), which gives to relatively well-governed countries, or a global 'Cash on Delivery' fund that would pay countries after making confirmed progress toward agreed-upon outcomes, thereby reducing the proliferation of aid projects," the authors write(Prieto/Roodman).

31 Jul 2010

BioScrip second-quarter 2010 revenue increases 25% to $412.0 million

BioScrip, Inc. announced 2010 second quarter revenue of $412.0 million, operating income of $13.5 million and net income of $3.1 million, or $0.06 per diluted share. Second quarter adjusted earnings per share (detailed in schedule 5) was $0.07 per diluted share. Adjusted EBITDA for the quarter was $18.4 million. All 2010 per share amounts have been adjusted to reflect the Company's issuance of 13.1 million shares in conjunction with the acquisition of CHS.

30 Jul 2010

Kiehl's Since 1851 inaugurates LifeRide to raise funds for amfAR

Maintaining its long-standing tradition of supporting HIV/AIDS charities, Kiehl's Since 1851, the venerable New York-based purveyor of fine quality skin and hair care, is pleased to announce a continued partnership with amfAR, The Foundation for AIDS Research.

30 Jul 2010

IRIN examines Global Humanitarian Assistance report, maps percentage of African budgets spent on health

"[H]umanitarian watchdog Development Initiatives outlines some of the needs, responses and funding trends" in humanitarian aid over the past decade in its 2010 Global Humanitarian Assistance (GHA) report, IRIN writes in an article that examines the organization's findings.

30 Jul 2010

Researchers discover three disease-causing genes in Salmonella

Researchers have discovered a novel mechanism in Salmonella that affects its virulence and its susceptibility to antibiotics by changing its production of proteins in a previously unheard of manner. This allows Salmonella to selectively change its levels of certain proteins to respond to inhospitable conditions.

30 Jul 2010

AIDS 2010 follow-up coverage: Global HIV/AIDS funding; HIV/AIDS studies, releases

Media outlets continued to reflect on news from the International AIDS Conference-AIDS 2010, which attracted over 19,000 participants from 197 countries to Vienna last week, according to the conference blog.

30 Jul 2010

SeraCare Life Sciences launches new product to diagnose HIV

SeraCare Life Sciences, Inc. today announced that the Company has launched a set of new products in its diagnostic controls and panels portfolio—the SeraCare HIV-1 Seroconversion Panels. Each of the six panels consists of a set of undiluted plasma samples from a single plasma donor collected over a period of time during the development of detectable specific antibodies to HIV in the blood, or seroconversion, and is highly characterized with enhanced product information.

30 Jul 2010

First Edition: July 29, 2010

In today's headlines, a new poll shows opposition to health reform declining, and Peter Orszag makes his exit as budget chief -- still pressing lawmakers to make tough budget choices while implementing the new law.

29 Jul 2010

AHF accuses Bristol-Myers Squibb of lying about cooperation with HIV/AIDS community

Today AIDS Healthcare Foundation (AHF) responded to a statement placed by drug giant Bristol-Myers Squibb (BMS) on its website defending its record on AIDS drug pricing and accessibility.

29 Jul 2010

Texas raises organ donor registry; D.C. not ready for medical marijuana sales; L.A. health department facing major service cuts

"Though Texas has the nation's lowest percentage of registered organ and tissue donors, several recent initiatives have more than doubled the state's donor rolls this year. The number enrolled in the Glenda Dawson Donate Life Texas Registry has ballooned since Jan. 1, when state law required Department of Public Safety clerks to ask all driver's license and ID card applicants whether they would like to register as organ donors. Since then, nearly 70,000 donors a month have joined the pool" (George, 7/27).

29 Jul 2010

PFSCM wins Supply Chain Innovation Award, Best Value Supply Chain Provider Award

The Partnership for Supply Chain Management, a partner of the U.S. Agency for International Development under the U.S. President's Emergency Plan for AIDS Relief, has won two prestigious awards for groundbreaking work on PEPFAR's Supply Chain Management System. PFSCM received the Supply Chain Innovation Award and Best Value Supply Chain Provider Award during the European Supply Chain and Logistics Summit held in Prague.

29 Jul 2010

Innovative campaign to increase awareness, use of female condom

The Washington AIDS Partnership today announced that the second phase of an innovative campaign to increase awareness and use of the female condom as a tool for HIV prevention will launch across the District this week.

29 Jul 2010

CMX157 shows potential to suppress replication of HIV in Phase 1 clinical trial

Chimerix, Inc., a biopharmaceutical company developing orally-available antiviral therapeutics, today announced the publication of research results demonstrating the potential of CMX157 (hexadecyloxypropyl tenofovir) to effectively suppress replication of human immunodeficiency virus (HIV) that cannot be treated with currently available nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs), including tenofovir disoproxil fumarate (Viread), due to the development of multi-drug resistance. Earlier this year, Chimerix initiated a dose-escalating Phase 1 clinical trial of CMX-157 to evaluate drug safety, tolerability and pharmacokinetics.

29 Jul 2010

HemoBioTech receives patent for HemoTech treatment of acute blood loss

HemoBioTech announced today the issuance of a new patent US 7,759,306 B2, Methods of Treating Acute Blood Loss. HemoBioTech has an exclusive worldwide license from Texas Tech University to commercialize the technology. The new patent continues to May 16, 2026. The major advance in HemoTech is the presence of Adenosine which has anti-inflammatory activity.

29 Jul 2010

HIV drug can raise the risk of heart disease: Study

There are a handful of drugs effective in treating HIV/AIDS. However new research shows that some of these drugs can increase the risk of heart attacks. The results come from a Garvan Institute of Medical Research study involving 20 people, 10 taking the drug Ritonavir and 10 others the drug Raltegravir for one month.

28 Jul 2010

HIV 1 News and Research

WHO expert: Faster MDR-TB test should be made available to vulnerable populations

Research establishes bases of possible future pharmaceutical drugs to combat AIDS virus

Consumers who have MMS should stop using it immediately, FDA warns

Research Roundup:COBRA subsidies; Children's insurance and dental coverage; Adopting health IT; Race and heart treatments

Opinions: IDUs and HIV; AIDS 2010; International Violence Against Women Act

Recent releases in Global Health

BioScrip second-quarter 2010 revenue increases 25% to $412.0 million

Kiehl's Since 1851 inaugurates LifeRide to raise funds for amfAR

IRIN examines Global Humanitarian Assistance report, maps percentage of African budgets spent on health

Researchers discover three disease-causing genes in Salmonella

AIDS 2010 follow-up coverage: Global HIV/AIDS funding; HIV/AIDS studies, releases

SeraCare Life Sciences launches new product to diagnose HIV

First Edition: July 29, 2010

AHF accuses Bristol-Myers Squibb of lying about cooperation with HIV/AIDS community

Texas raises organ donor registry; D.C. not ready for medical marijuana sales; L.A. health department facing major service cuts

PFSCM wins Supply Chain Innovation Award, Best Value Supply Chain Provider Award

Innovative campaign to increase awareness, use of female condom

CMX157 shows potential to suppress replication of HIV in Phase 1 clinical trial

HemoBioTech receives patent for HemoTech treatment of acute blood loss

HIV drug can raise the risk of heart disease: Study

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News